bmi 25 glp 1 A new Penn Medicine study is drawing attention after researchers found that women taking GLP-1 medications had lower odds of developing breast cancer compared to women who were not taking the drugs Who is (and is Not)

The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus

They should not be interpreted as evidence that compounded semaglutide or tirzepatide are safe or effective for everyone

The Ozempic Lawsuit is still ongoing

The primary concern relates not to direct drug interactions between most injectable GLP-1 agonists and levothyroxine, but rather to the potential impact on thyroid monitoring and the theoretical risk associated with thyroid C-cell tumours observed in animal studies

The mechanism and the results are completely different

Keep supportive supplements on hand